Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Sarah Morin-Zorman"'
Autor:
Sarah Morin-Zorman, Christian Wysocki, Jieqing Zhu, Hongmei Li, Sylvain Zorman, Catherine Matte-Martone, Edwina Kisanga, Jennifer McNiff, Dhanpat Jain, David Gonzalez, David M. Rothstein, Fadi G. Lakkis, Ann Haberman, Warren D. Shlomchik
Publikováno v:
Blood Advances, Vol 3, Iss 14, Pp 2082-2092 (2019)
Abstract: Graft-versus-host disease (GVHD) is a major cause of morbidity and mortality in allogeneic hematopoietic stem cell transplantation (alloSCT). By static microscopy, cutaneous GVHD lesions contain a mix of T cells and myeloid cells. We used 2
Externí odkaz:
https://doaj.org/article/fd7cc965ad0547689fdd3e6ee81d0457
Publikováno v:
Frontiers in Immunology, Vol 7 (2016)
Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT) is a curative treatment for a wide variety of hematological diseases. In 30% of the cases, a geno-identical donor is available. Any other situation displays some level of Human Leukocyte Anti
Externí odkaz:
https://doaj.org/article/6d72b0058c5344868bcfb5f1467726f3
Autor:
Hongmei Li, David M. Rothstein, Sylvain Zorman, Edwina P Kisanga, Jennifer M. McNiff, Sarah Morin-Zorman, Warren D. Shlomchik, Christian A. Wysocki, Jieqing Zhu, Dhanpat Jain, Catherine Matte-Martone, Ann M. Haberman, David G. Gonzalez, Fadi G. Lakkis
Publikováno v:
Blood advances. 3(14)
Graft-versus-host disease (GVHD) is a major cause of morbidity and mortality in allogeneic hematopoietic stem cell transplantation (alloSCT). By static microscopy, cutaneous GVHD lesions contain a mix of T cells and myeloid cells. We used 2-photon in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::418e23246688dbe03394a92d9e3c8a85
https://pubmed.ncbi.nlm.nih.gov/31296496
https://pubmed.ncbi.nlm.nih.gov/31296496
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 7 (2016)
Frontiers in Immunology, Vol 7 (2016)
Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT) is a curative treatment for a wide variety of hematological diseases. In 30% of the cases, a geno-identical donor is available. Any other situation displays some level of Human Leukocyte Anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf3306d0d6b14fa2319498d441e80576
Autor:
David M. Rothstein, Fadi G. Lakkis, Warren D. Shlomchik, Catherine Matte-Martone, Christian A. Wysocki, Hung Sheng Tan, Kathryn W Juchem, Sarah Morin-Zorman, Srividhya Venkatesan
Publikováno v:
Blood. 122:4463-4463
Graft-versus-host disease (GVHD) limits the broader application of allogeneic hematopoietic stem cell transplantation. In prior studies we defined roles for both host and donor-derived antigen presenting cells (APCs) in the activation of alloreactive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a8c3074fbcd1f8c1a6074d3545068cc4
https://doi.org/10.1182/blood.v122.21.4463.4463
https://doi.org/10.1182/blood.v122.21.4463.4463
Autor:
Sarah Morin-Zorman, Christian Wysocki, Edwina Kisanga, David Gonzalez, David Rothstein, Fadi Lakkis, Ann Haberman, Warren D Shlomchik
Publikováno v:
Blood. 122:2004-2004
Graft-versus-host disease (GVHD) limits the broader application of allogeneic hematopoietic stem cell transplantation. In prior studies we defined roles for both host and donor-derived antigen presenting cells (APCs) in the activation of alloreactive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e1b721a32fa41bbb630b1507b5ed8e52
https://doi.org/10.1182/blood.v122.21.2004.2004
https://doi.org/10.1182/blood.v122.21.2004.2004